4
Changes in Ownership
AGIOS PHARMACEUTICALS, INC. Filed Acc 0001209191-17-053461
Chief Executive Officer sold 35,000 shares at $67.12 ($2,349,200)
- Chief Executive Officer acquired 35,000 shares (option exercise)
- Chief Executive Officer gave 500 shares (gift)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Schenkein David P Chief Executive Officer | 2017-09-07 | Gift | −500 | 271,772 | I | ||
| Schenkein David P Chief Executive Officer | 2017-09-18 | Option exercise | +35,000 | $0.30 | $10,588 | 35,000 | D |
| Schenkein David P Chief Executive Officer | 2017-09-18 | Sale | −35,000 | $67.12 | $2,349,200 | 0 | D |
| Derivatives | |||||||
| Schenkein David P Chief Executive Officer | 2017-09-18 | Option exercise · Stock option (right to buy) | −35,000 | 118,656 | D | ||
| Open-market sales · 35,000 sh · avg $67.12 · $2,349,200 | |||||||
Loading xslF345X03/doc4.xml…